Terms: = Prostate cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
13 results:
1. Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
Lang B; Cao C; Zhao X; Wang Y; Cao Y; Zhou X; Zhao T; Wang Y; Liu T; Liang W; Hu Z; Tian X; Zhang J; Yan Y
Eur J Med Res; 2023 Jul; 28(1):239. PubMed ID: 37461056
[TBL] [Abstract] [Full Text] [Related]
2. The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20 ng/mL.
Wang ZB; Wei CG; Zhang YY; Pan P; Dai GC; Tu J; Shen JK
Biomed Res Int; 2021; 2021():3995789. PubMed ID: 34671673
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical prostatectomy From a Statewide Improvement Collaborative.
Auffenberg GB; Qi J; Dunn RL; Linsell S; Kim T; Miller DC; Tosoian J; Sarle R; Johnston WK; Kleer E; Ghani KR; Montie J; Peabody J
JAMA Surg; 2021 Mar; 156(3):e206359. PubMed ID: 33471043
[TBL] [Abstract] [Full Text] [Related]
4. A Differential Item Functioning Analysis of the EQ-5D in cancer.
Smith AB; Cocks K; Parry D; Taylor M
Value Health; 2016 Dec; 19(8):1063-1067. PubMed ID: 27987634
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Pathways: Targeting DNA Repair Pathway Defects Enriched in Metastasis.
Corcoran NM; Clarkson MJ; Stuchbery R; Hovens CM
Clin Cancer Res; 2016 Jul; 22(13):3132-7. PubMed ID: 27169997
[TBL] [Abstract] [Full Text] [Related]
6. Testosterone in Androgen Receptor Signaling and DNA Repair: Enemy or Frenemy?
Chua ML; Bristow RG
Clin Cancer Res; 2016 Jul; 22(13):3124-6. PubMed ID: 27166396
[TBL] [Abstract] [Full Text] [Related]
7. Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors.
Von Hoff DD; Mita MM; Ramanathan RK; Weiss GJ; Mita AC; LoRusso PM; Burris HA; Hart LL; Low SC; Parsons DM; Zale SE; Summa JM; Youssoufian H; Sachdev JC
Clin Cancer Res; 2016 Jul; 22(13):3157-63. PubMed ID: 26847057
[TBL] [Abstract] [Full Text] [Related]
8. Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant prostate cancer.
Hussain M; Le Moulec S; Gimmi C; Bruns R; Straub J; Miller K;
Clin Cancer Res; 2016 Jul; 22(13):3192-200. PubMed ID: 26839144
[TBL] [Abstract] [Full Text] [Related]
9. Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive prostate cancer Cells to Ionizing Radiation.
Hedayati M; Haffner MC; Coulter JB; Raval RR; Zhang Y; Zhou H; Mian O; Knight EJ; Razavi N; Dalrymple S; Isaacs JT; Santos A; Hales R; Nelson WG; Yegnasubramanian S; DeWeese TL
Clin Cancer Res; 2016 Jul; 22(13):3310-3319. PubMed ID: 26831716
[TBL] [Abstract] [Full Text] [Related]
10. Biological & physiological aspects of action of insulin-like growth factor peptide family.
Pavelić J; Matijević T; Knezević J
Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
[TBL] [Abstract] [Full Text] [Related]
11. Gene expression of insulin-like growth factors and receptors in neoplastic prostate tissues: correlation with clinico-pathological parameters.
Figueroa JA; De Raad S; Speights VO; Rinehart JJ
Cancer Invest; 2001; 19(1):28-34. PubMed ID: 11291553
[TBL] [Abstract] [Full Text] [Related]
12. Effective and economical option for pain palliation in prostate cancer with skeletal metastases: 32P therapy revisited.
Shah Syed GM; Maken RN; Muzzaffar N; Shah MA; Rana F
Nucl Med Commun; 1999 Aug; 20(8):697-702. PubMed ID: 10451877
[TBL] [Abstract] [Full Text] [Related]
13. Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop.
Figueroa JA; Lee AV; Jackson JG; Yee D
J Clin Endocrinol Metab; 1995 Dec; 80(12):3476-82. PubMed ID: 8530586
[TBL] [Abstract] [Full Text] [Related]
